Changes in brain volume in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) differentiate it from multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), new data suggest.
Changes in brain volume in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) differentiate it from multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), new data suggest.